Nurix Therapeutics Inc. (NRIX)
19.89
1.29 (6.94%)
At close: Jan 15, 2025, 1:42 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -2.35 | -3.63 | -10.55 | -15.45 | -34.03 | -32.48 |
| PS Ratio | 4.39 | 15.59 | 41.55 | 37.49 | 23.73 | 8.18 |
| PB Ratio | 1.69 | 1.98 | 3.61 | 2.30 | -12.79 | -8.31 |
| P/FCF Ratio | -3.77 | -3.5 | -13.73 | -144.18 | -703.28 | -9.2 |
| P/OCF Ratio | -4.15 | -3.77 | -14.65 | -8.35K | 1.23K | -9.67 |
| OCF/S Ratio | -1.06 | -4.14 | -2.84 | -0.00 | 0.02 | -0.85 |
| Debt / Equity Ratio | 0.15 | 0.04 | 0.04 | n/a | n/a | n/a |
| Quick Ratio | 3.40 | 4.52 | 4.70 | 6.70 | 2.44 | 1.24 |
| Current Ratio | 3.40 | 4.51 | 4.70 | 6.70 | 2.44 | 1.24 |
| Asset Turnover | 0.22 | 0.09 | 0.06 | 0.04 | 0.71 | 0.82 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.72 | -0.55 | -0.34 | -0.15 | 0.38 | 0.26 |
| Return on Assets (ROA) | -0.4 | -0.4 | -0.25 | -0.11 | -0.49 | -0.21 |
| Return on Capital (ROIC) | -0.58 | -0.53 | -0.29 | -0.18 | -0.8 | -0.78 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -145.69% | 72.02% | 79.56% | -273.14% | -44.71% | -8.18% |
| Net Profit Margin | -186.98% | -429.87% | -393.93% | -242.66% | -69.74% | -25.18% |
| Pretax Profit Margin | -186.98% | -466.93% | -393.49% | -357.9% | -68.97% | -23.82% |
| Operating Profit Margin | -201.41% | -476.01% | -396.26% | -364.66% | -71.46% | -26.01% |
| FCF Margin | -116.6% | -445.42% | -302.61% | -26% | -3.37% | -88.84% |
| EBITDA Margin | -183.68% | -448.03% | -375.81% | -352.43% | -63.9% | -18.03% |